Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
Allogeneic stem cell transplan...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
Allogeneic stem cell transplantation for lymphoproliferative disease using BEAM-Campath conditioning: An effective regime with low procedure-related toxicity.
Detalhes bibliográficos
Main Authors:
Cull, G
,
Haynes, A
,
Byrne, J
,
Carter, G
,
Miflin, G
,
Hale, G
,
Waldmann, H
,
Russell, N
Formato:
Journal article
Publicado em:
1999
Exemplares
Descrição
Registos relacionados
Registo fonte
Registos relacionados
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Por: Cull, G, et al.
Publicado em: (2000)
Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
Por: Russell, N, et al.
Publicado em: (1999)
T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1988)
Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
Por: Hale, G, et al.
Publicado em: (1998)
Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
Por: Chakrabarti, S, et al.
Publicado em: (2004)